It likely causes denaturation of a substantial fraction of serum proteins, leading to a state of serum-starved quiescence or cell death.
Our data demonstrates that a clinically guided antihypertensive treatment is effective in reversing the low-grade proinflammatory state of serum cytokines found in postmenopausal women and support extracardiac benefits from diuretics and renin angiotensin system antagonists.
If the disease progresses to castration-resistant prostate cancer (CRPC), a state of resistance to the therapeutic regiment of serum androgen suppression, the prognosis becomes poor, with an expected survival for patients with metastases of less than 19 months [3].
21 Using this protocol, we demonstrated that short-term, clinically guided antihypertensive treatment is effective in reversing the low-grade proinflammatory state of serum cytokines found in older women with different metabolic disorders, known as "inflammaging".
In ICU patients with normal serum creatinine (SCr), a state of increased renal drug excretion has been described (creatinine clearance ≥130 ml/min/1.73 m2), and named augmented renal clearance (ARC).
Given the variation in the CAG repeat length of the androgen receptor (AR) gene and its inverse effect on the receptor activity, the alleles with longer CAG repeat length are expected to result in diminished androgen receptor activity, which might lead to a state of biochemical hyperandrogenism, i.e. increased serum levels of androgens as demonstrated in a couple of previous studies [5], [7].
LH levels are increased in the face of normal or elevated serum testosterone, reflecting a state of androgen resistance.
In ICU patients with normal serum creatinine (SCr), a state of increased renal drug excretion has been described (creatinine clearance ≥130 ml/min/1.73 m), and named augmented renal clearance (ARC).
In the present study, effect of feeding was not tested, as this condition abolishes the steady-state of serum glucose and insulin needed for an accurate compartmental analysis of liver metabolism.
The pharmacokinetics of FA shows a linear increase in the steady-state concentration of serum folate levels for increasing dose, when supplemented doses are administered [ 11].
